Buys
Open market- Shares
- Avg price
- Total value
Patricia Carr - SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc
Issuer-level insider activity
- Role
- SVP, Chief Accounting Officer
- Issuer ticker
- JAZZ on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Patricia Carr in Jazz Pharmaceuticals plc
Sells
Open market- Shares
- -13,636
- Avg price
- $180.27
- Total value
- -$2,458,094
Net
Past year- Shares
- -13,636
- Share %
- -100%
- Total value
- -$2,458,094
Reported holdings for Patricia Carr in Jazz Pharmaceuticals plc
Form 4 holding
SVP, Chief Accounting Officer
Jazz Pharmaceuticals plc
- Security class
- Ordinary Shares
- Shares / value
- 6,512
- Estimated value
- $1,191,305
- Report date
- 09 Mar 2026
- Price
- $182.94
- Ownership
- Direct
Form 4 holding
SVP, Chief Accounting Officer
Jazz Pharmaceuticals plc
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 05 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Patricia Carr in Jazz Pharmaceuticals plc
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.